MBOT Stock Gains Following FDA Submission of the LIBERTY System

Microbot Medical announces the submission of its LIBERTY System for FDA marketing clearance.

Articles similaires

healthtechzone.com - 11/Dec 15:01

zacks.com - 20/Dec 14:03

Smith & Nephew announces FDA clearance for its CORIOGRAPH platform for total hip arthroplasty.

zacks.com - 16/Dec 12:35

Zimmer Biomet's OsseoFit Stemless Shoulder System gets FDA 510(k) approval. The company expects to launch the system in the first quarter of 2025.

healthtechzone.com - 16/Dec 13:33

zacks.com - 20/Dec 15:05

Eli Lilly stock gains as the FDA removes tirzepatide drugs from the drug shortage list following a thorough reevaluation.

zacks.com - 20/Dec 15:05

Eli Lilly stock gains as the FDA removes tirzepatide drugs from the drug shortage list following a thorough reevaluation.

zacks.com - 13/Dec 13:04

QGEN announces the launch of IPA Interpret to extend the analysis capabilities of a human-curated knowledge base with AI technology.

stockhead.com.au - 19/Dec 08:08

Orthocell is well placed for the commercial launch of its Remplir nerve-repair device once clearance is received from the US ...

washingtontimes.com - 17/Dec 15:23

U.S. stock indexes are edging back on Tuesday and trimming some of their stellar gains for the year.

zacks.com - 19/Dec 14:19

Accuray announces positive study data for its CyberKnife System in treating brainstem metastases.